The Phase-3 trials for the vaccine were conducted on 25,800 volunteers. Bharat Biotech has submitted the Phase-3 efficacy data earlier this week. Covaxin, the country’s first indigenous COVID-19 vaccine, was developed with seed strains received from the National Institute of Virology.Explained | What Phase 3 data submission of Covaxin means, how close is it to WHO approval, and comparison with other jabs
The Phase-3 trials for the vaccine were conducted on 25,800 volunteers. Bharat Biotech has submitted the Phase-3 efficacy data earlier this week. Covaxin, the country’s first indigenous COVID-19 vaccine, was developed with seed strains received from the National Institute of Virology.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment